Siemens Healthineers AG (ETR:SHL)
Germany · Delayed Price · Currency is EUR 34.40
-0.70 (-1.99%)
Jun 11, 2026, 5:37 PM CET
Siemens Healthineers AG Cash Flow Statement
Financials in millions EUR. Fiscal year is October - September.
Millions EUR. Fiscal year is Oct - Sep.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 |
Net Income | 2,121 | 2,168 | 1,959 | 1,525 | 2,054 | 1,746 |
Depreciation & Amortization | 1,236 | 1,296 | 1,223 | 1,557 | 1,343 | 1,039 |
Other Adjustments | 794 | 853 | 763 | 488 | 776 | 546 |
Change in Receivables | -364 | -417 | -443 | -769 | -478 | -720 |
Changes in Inventories | -147 | -76 | 39 | -453 | -481 | -22 |
Changes in Accounts Payable | 172 | 229 | -62 | -20 | 247 | 318 |
Changes in Income Taxes Payable | -756 | -577 | -845 | -899 | -877 | -808 |
Changes in Unearned Revenue | 166 | 164 | 88 | 141 | 544 | 325 |
Changes in Other Operating Activities | - | -107 | 104 | 549 | -625 | 509 |
Operating Cash Flow | 3,224 | 3,532 | 2,826 | 2,119 | 2,504 | 2,933 |
Operating Cash Flow Growth | -9.00% | 24.98% | 33.37% | -15.38% | -14.63% | 52.13% |
Purchases of Intangible Assets | -796 | -818 | -696 | -838 | -852 | -674 |
Purchases of Investments | -3 | -2 | -4 | -7 | -2 | -12 |
Proceeds from Sale of Investments | 121 | 128 | 80 | 12 | 17 | 12 |
Payments for Business Acquisitions | -54 | -216 | -46 | -235 | -29 | -13,467 |
Proceeds from Business Divestments | 3 | 3 | - | - | -2 | - |
Investing Cash Flow | -729 | -906 | -666 | -1,069 | -868 | -14,140 |
Short-Term Debt Issued | -876 | -1,065 | 5 | 1,252 | -20 | -17 |
Net Short-Term Debt Issued (Repaid) | -876 | -1,065 | 5 | 1,252 | -20 | -17 |
Long-Term Debt Issued | 13 | 61 | - | - | - | - |
Long-Term Debt Repaid | -195 | -193 | -216 | -190 | -149 | -138 |
Net Long-Term Debt Issued (Repaid) | -182 | -132 | -216 | -190 | -149 | -138 |
Issuance of Common Stock | - | - | - | - | - | 2,309 |
Repurchase of Common Stock | -301 | -301 | - | -421 | -309 | -255 |
Net Common Stock Issued (Repurchased) | -301 | -301 | - | -421 | -309 | 2,054 |
Common Dividends Paid | -1,118 | -1,066 | -1,063 | -1,066 | -955 | -856 |
Other Financing Activities | -439 | -475 | -384 | -307 | -213 | 10,796 |
Financing Cash Flow | -2,916 | -3,038 | -1,657 | -730 | -1,644 | 11,839 |
Effect of Exchange Rate Changes on Cash and Cash Equivalents | -74 | -97 | -66 | -191 | 122 | 34 |
Net Cash Flow | -496 | -508 | 437 | 130 | 114 | 666 |
Free Cash Flow | 3,224 | 3,532 | 2,826 | 2,119 | 2,504 | 2,933 |
Free Cash Flow Growth | -8.72% | 24.98% | 33.37% | -15.38% | -14.63% | 52.13% |
FCF Margin | 13.98% | 15.11% | 12.64% | 9.77% | 11.53% | 16.30% |
Free Cash Flow Per Share | 2.86 | 3.14 | 2.52 | 1.89 | 2.22 | 2.66 |
Levered Free Cash Flow | 1,708 | 1,876 | 2,278 | 3,446 | 2,020 | 2,933 |
Unlevered Free Cash Flow | 2,994 | 3,325 | 2,727 | 2,564 | 2,298 | 3,230 |